Abacavir, dolutegravir, and lamivudine and Nia-Chrom
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Nia-Chrom and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: chromium picolinate
Brand name: Cr-GTF, CRM, Chromium GTF
Synonyms: Chromium picolinate, Chromium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Niacin
- Abacavir, dolutegravir, and lamivudine-Niacin and Lovastatin
- Abacavir, dolutegravir, and lamivudine-Niacin and Simvastatin
- Abacavir, dolutegravir, and lamivudine-Niacin Capsules and Tablets
- Abacavir, dolutegravir, and lamivudine-Niacin Controlled-Release Capsules and Controlled-Release Tablets
- Abacavir, dolutegravir, and lamivudine-Niacin SR
- Nia-Chrom-Abacavir, Lamivudine and Zidovudine Tablets
- Nia-Chrom-Abacavir, lamivudine, and zidovudine
- Nia-Chrom-Abaloparatide
- Nia-Chrom-Abaloparatide Subcutaneous
- Nia-Chrom-Abatacept
- Nia-Chrom-Abatacept Auto-Injectors